Clinicopathological features of KRAS mutation secondary to EGFR-TKI targeted therapy in lung adenocarcinoma
WEI Jing-yuan
ZHANG Jian-zhong
SHEN Xiao-ying
WANG Hui-fang
WU Ji-hua
Keywords：lung adenocarcinomaPleural effusionEGFRDouble mutationKARS acquired mutation
Publication Date：2023-05-28
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：4( 417-419,424 )